In this study, we designed and generated two new minicircle plasmids encoding full COL7A1 gene regulated by different human promoters and tested their potential to be used in gene replacement therapy for RDEB. This evidence concerns the gene COL7A1 and recessive dystrophic epidermolysis bullosa.